Abrezekimab (Anti-IL-13)
Abrezekimab (anti-IL-13) is a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. It can be used in research of asthma. MW: 145.5 KD.
| Trivial name | UCB4144; VR 942 |
| Catalog Number | A2454 |
| CAS# | 2043952-59-4 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/abrezekimab--anti-il-13.html |